ClinicalTrials.gg
CompletedNCT04566549Updated Aug 18, 2021

The Safety and Efficacy Evaluation of Hair Products Containing Probiotics

A Phase 2 interventional study of Test group Probiotic Shampoo and Placebo group in Skin Problems, sponsored by GenMont Biotech Incorporation. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-18.

Sponsored by GenMont Biotech Incorporation · Phase 2, Interventional, and Supportive care

Phase
Phase 2
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

Previous studies on skin health with Lactic acid bacteria (LAB) have been published for many years, including prevention of skin diseases and improvement of skin conditions. In this clinical study, the investigators researched the benefit effects of heat-killed Lactobacillus paracasei shampoo on scalp and hair healthcare.

Read the detailed description

To evaluate the safety and efficacy of hair products containing probiotics

02

Conditions studied

  • Skin Problems

Keywords

  • Hair health
  • Scalp health
  • Probiotics
  • Scalp microbiota
03

In context

Lead sponsor

GenMont Biotech Incorporation is the lead sponsor of 11 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Healthy volunteers between the ages of 20-70.

Exclusion criteria

Exclusion Criteria:

  • Subjects are undergoing medical therapy for scalp, hair diseases or diabetes mellitus.
  • Subjects with cosmetics allergy.
  • Subjects had accepted the scalp surgery such as Follicular Unit Transpalnt, Follicular Unit Extraction in the past half year.
  • Subjects with pregnancy or breast-feeding.
05

Study design

Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
21 participants (actual)

Study arms

  • Placebo comparator
    Placebo group

    Shampoo base without probiotics inculding Aqua、Sodium Lauryl Ether Sulphate、Cocamidopropyl Betaine、Cocoamide DEA、Sodium、Polyquaternium-10 、Disodium EDTA、Acrylates Copolymer、Citric Acid、Phenoxyethanol、Fragrance.

    Combination Product: Placebo group

  • Active comparator
    Test group

    Shampoo base with probiotics inculding Aqua、Sodium Lauryl Ether Sulphate、Cocamidopropyl Betaine、Cocoamide DEA、Sodium、Polyquaternium-10 、Disodium EDTA、Acrylates Copolymer、Citric Acid、Phenoxyethanol、Fragrance、Heat-killed Lactobacillus paracasei powders (5x10\^8 cells/ g-shampoo).

    Combination Product: Test group Probiotic Shampoo

Interventions

  • Combination productTest group Probiotic Shampoo

    Probiotic Shampoo

    Also known as: Probiotic Group

  • Combination productPlacebo group

    Shampoo base

    Also known as: Control Group

06

What researchers measure

Primary outcomes

  1. Skin Microbiota

    The changes of scalp microbiota will be evaluated by NGS or qPCR analysis at baseline and different timepoint post-intervention.

    Time frame: Baseline, 4 weeks and 8 weeks

Secondary outcomes

  1. The sebum on scalp

    The scalp sebum will be measured by Sebumeter SM815 (C+K, Germany) at baseline and different timepoint post-intervention.

    Time frame: Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks

  2. The scalp flakes (dandruff)

    The scalp flakes will be evaluated by D-SQAME ® DANDRUFF TESTER at baseline and different timepoint post-intervention.

    Time frame: Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks

  3. The hair density (hairs/scalp area)

    The hair number in a constant scalp area will be measured by Aramo TSII skin/hair diagnosis (Aramhuvis Co., Ltd. Korea) at baseline and different timepoint post-intervention.

    Time frame: Baseline, 4 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks

  4. Adverse Event

    Any adverse event, such as erythema,rash, itching and so on will be recorded during the intervention.

    Time frame: Baseline and 28 weeks

  5. Single application closed patch epicutaneous test under occlusion

    Probiotics on skin will be evaluated by Human Patch test. The Human Patch test method according to the Guidelines of Human Patch test Standards for Cosmetics, Taiwan Food and Drug Administration, 2019 edition.

    Time frame: 1 hour, 24 hours and 48 hour

  6. Repeated application closed patch epicutaneous test under occlusion

    The irritation potential of probiotics on skin will be evaluated by Human Patch test. The Human Patch test method according to the Guidelines of Human Patch test Standards for Cosmetics, Taiwan Food and Drug Administration, 2019 edition.

    Time frame: Day 1, 2, 3, 4 and 5

07

Study locations

1 site
  • Chia Nan University of Pharmacy and Science
    Tainan, 71710, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04566549
Lead sponsor
GenMont Biotech Incorporation
Collaborators
Chia Nan University of Pharmacy and Science
Responsible party
Sponsor
First posted
Sep 28, 2020
Start date
Jul 6, 2020
Primary completion
Dec 6, 2020
Completion
Feb 6, 2021
Last update
Aug 18, 2021

Study contacts

Ching-Gong Lin, PhD
principal investigator · Chia Nan University of Pharmacy & Science

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Probiotic

Start the discussion